mirzotamab clezutoclax
Generic: Mirzotamab Clezutoclax
mirzotamab clezutoclax: 1 clinical trial tracked.
mirzotamab clezutoclax evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about mirzotamab clezutoclax, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trials (1)
Phase Ib Trial of ABBV-637 or ABBV-155 in Combination With ERAS-801 for Glioblastoma With Amplification of the Epidermal Growth Factor Receptor
Primary endpoint: Dose limiting toxicity (DLT)
InterventionalRandomizedopen60 targetStarted 2025-04Completion 2028-048 sites · United StatesMemorial Sloan Kettering Cancer Center